在骨髓瘤中对循环林依赖蛋白激酶家族的表达和预后的全面分析
Jianshui Mao1, Hui-Min Li1, Zhidan Huang1
1Department of Orthopedics, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, P R China.
Nucleosides, nucleotides & nucleic acids
|October 2, 2024
概括
循环素依赖蛋白激酶 (CDK) 在骨髓瘤中表现多样,特定的CDK (3, 6, 9, 18) 被确定为潜在的治疗点. 这些CDK可能会影响癌症中的免疫检查点和m6A修饰.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 循环素依赖蛋白激酶 (CDK) 对癌细胞的存活和生长至关重要,这使得它们成为有前途的治疗点.
- 关于CDK表达特征和骨髓瘤的预后意义的研究有限.
研究的目的:
- 为了研究骨髓瘤中差异性CDK表达.
- 在骨髓瘤患者的CDK中识别预后生物标志物.
- 探索CDKs,microRNAs (miRNAs),免疫检查点和骨髓瘤中m6A相关基因之间的关系.
主要方法:
- 对骨髓瘤的基因和microRNA表达数据使用基因表达集 (GEO) 和TARGET数据库的数据集进行了分析.
- 使用Cytoscape构建了一个miRNAs和CDKs网络.
- 进行了功能和途径丰富分析.
- 研究了CDK,免疫检查点基因和m6A相关基因之间的相互作用.
主要成果:
- 与正常样本相比,CDK1-5,16-18和17在骨髓瘤中表达显著更高.
- 在骨髓瘤中,CDK7-9,11B,16和20的表达显著降低.
- CDK3和18的低表达,或CDK6和9的高表达,与良好的预后和更长的存活相关.
- 在CDK表达,免疫检查点基因和m6A相关基因之间观察到显著的关联.
结论:
- CDK3,6,9和18被确定为骨髓瘤的潜在治疗标.
- CDKs在骨髓瘤细胞中调节m6A修饰和免疫检查点方面发挥作用.
相关概念视频
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:39Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:21Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K